REGENXBIO
RGNX
HK$66.01
Share price
-4.32%
Change (1 day)
-41.12%
Change (1 year)
Categories
Market capitalization of REGENXBIO (RGNX)
Market cap: HK$3.32 Billion
As of July 2025 REGENXBIO has a market cap of HK$3.32 Billion. This makes REGENXBIO the world's 7403th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of REGENXBIO from 2015 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | HK$3.32 B | 16.7% |
| 2024 | HK$2.85 B | -53.78% |
| 2023 | HK$6.16 B | -19.61% |
| 2022 | HK$7.67 B | -29.65% |
| 2021 | HK$10.90 B | -17.25% |
| 2020 | HK$13.17 B | 11.65% |
| 2019 | HK$11.80 B | -0.53% |
| 2018 | HK$11.86 B | 46.65% |
| 2017 | HK$8.09 B | 112.45% |
| 2016 | HK$3.80 B | 12.49% |
| 2015 | HK$3.38 B |
End of Day market cap according to different sources
On Jul 29th, 2025 the market cap of REGENXBIO was reported to be:
HK$3.31 Billion
HK$3.32 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | HK$7.38 B | 122.01% | 🇺🇸 USA |